Today: 5 March 2026
Subscribe
Browse Category

Stock Market 31 October 2025

Luminar’s LiDAR Rollercoaster: LAZR Stock Soars on Buyout Buzz, Crashes on Cash Crunch – October 2025 Update

Luminar’s LiDAR Rollercoaster: LAZR Stock Soars on Buyout Buzz, Crashes on Cash Crunch – October 2025 Update

Luminar Technologies’ shares plunged 42% to $1.21 by Oct. 31 after warning it may run out of cash in early 2026 and announcing a 25% workforce cut. Founder Austin Russell made a non-binding buyout offer, but the company suspended financial guidance amid deep losses and missed debt payments. CFO resignation and disputes with Volvo added to the turmoil.
31 October 2025
·
Robinhood’s Wild 2025 Ride: HOOD Stock Skyrockets 250% Amid Crypto Boom, New Gambits & Big Risks

Robinhood’s Wild 2025 Ride: HOOD Stock Skyrockets 250% Amid Crypto Boom, New Gambits & Big Risks

Robinhood Markets shares have soared over 200% in 2025, hitting a record $153 in October before settling near $138. The company’s Q2 revenue jumped 45% to $989 million, with net income doubling to $386 million. Robinhood acquired Bitstamp for $200 million and launched new banking and sports betting products. Regulatory scrutiny persists after a $45 million SEC settlement in January.
31 October 2025
··
Astera Labs Stock Skyrockets on AI Buzz and Photonics Deal – Can ALAB Keep Climbing?

Astera Labs Stock Skyrockets on AI Buzz and Photonics Deal – Can ALAB Keep Climbing?

Astera Labs shares surged over 12% to $191 intraday on Oct. 31, 2025, though still below their September high of $262.90. The stock rebounded after a volatile month that included a 19% drop on Oct. 15 and the Oct. 22 acquisition of aiXscale Photonics. Q2 revenue jumped 150% year-over-year to $191.9 million, beating estimates. Institutional investors hold about 60% of shares, while insiders sold over $190 million in August.
31 October 2025
··
Newell Brands Stock Crashes on Tariff Woes – Inside NWL’s Plunge and Turnaround Struggles

Newell Brands Stock Crashes on Tariff Woes – Inside NWL’s Plunge and Turnaround Struggles

Newell Brands shares plunged 32% on October 31, 2025, closing at $3.25 after weak Q3 results and a sharp 2025 outlook cut. Net sales fell to $1.81 billion, missing estimates, and gross margin declined to 34.1% on tariff and cost pressures. The company now expects full-year sales to drop up to 5% and slashed earnings and cash flow guidance. Year-to-date, the stock is down over 65%.
31 October 2025
·
ONDS Stock’s Wild Ride: Drone Darling or Bubble in the Making?

ONDS Stock’s Wild Ride: Drone Darling or Bubble in the Making?

Ondas Holdings (NASDAQ: ONDS) surged over 1,000% to an $11.70 high in October 2025, then plunged about 45% to $6.30 by month’s end. The stock remains up 150% year-to-date but has fallen 23% in the last 10 days amid heavy profit-taking. Wall Street rates ONDS a “Moderate Buy,” with analysts citing high valuation and execution risks. Trading volume spiked as shares broke technical support levels.
31 October 2025
···
Opendoor’s Meteoric 1600% Rally – Can the Real Estate Disruptor Keep Soaring or Will It Stumble Next?

Opendoor’s Meteoric 1600% Rally – Can the Real Estate Disruptor Keep Soaring or Will It Stumble Next?

Opendoor Technologies shares surged over 1,600% from under $1 in June to $10.87 by mid-September 2025, before settling near $7.34 in late October. The company named Kaz Nejatian CEO in September and announced it would accept cryptocurrency for home purchases, sparking brief rallies. Analysts remain skeptical, with average price targets far below current levels. Q3 earnings are set for November 6.
31 October 2025
···
Nokia Stock Skyrockets 25% on Nvidia’s $1B AI Bet – What’s Next for NOK Investors?

Nokia Stock Skyrockets 25% on Nvidia’s $1B AI Bet – What’s Next for NOK Investors?

Nokia shares surged to nearly $8 after Nvidia announced a $1 billion investment for a 2.9% stake, pushing the stock up 20–25% in one day and to decade highs. Q3 2025 earnings beat forecasts, with revenue up 12% year-over-year. Multiple analysts upgraded the stock, raising targets to as high as $8.50. Shares pulled back to $6.89 but remain up 69% year-to-date.
31 October 2025
····
China’s Soybean Buying Spree After Trade Truce Thrills Farmers, Shakes Markets

China’s Soybean Buying Spree After Trade Truce Thrills Farmers, Shakes Markets

China agreed to buy 12 million metric tons of U.S. soybeans by January and 25 million tons annually for three years under a trade truce announced Oct. 30. State grain trader COFCO purchased the first U.S. soybeans of the year just before the Trump-Xi summit. Chicago soybean futures hit 15-month highs on the news. Analysts say the deal restores pre-trade-war levels but warn tariff issues remain unresolved.
31 October 2025
··
Marvell Technology Stock Soars on AI Boom: Latest Price, Hot News & 2025 Outlook

Marvell Technology Stock Soars on AI Boom: Latest Price, Hot News & 2025 Outlook

Marvell Technology shares trade in the high-$80s, down about 20% year-to-date but up 15–20% from last fall. The stock jumped over 5% in late October after Amazon cited strong demand for Trainium AI chips, which Marvell helps produce. About 74% of Marvell’s revenue now comes from cloud data center products, with AI-related sales rising rapidly. Marvell faces competition from Broadcom, Nvidia, and AMD in cloud and AI chips.
31 October 2025
·
Getty Images Stock Soars on AI Deal – A $1 Billion Visual Content Giant’s 2025 Outlook Revealed

Getty Images Stock Soars on AI Deal – A $1 Billion Visual Content Giant’s 2025 Outlook Revealed

Getty Images (NYSE: GETY) surged nearly 40–50% intraday on October 31, 2025, after announcing a major AI partnership, closing at $2.82 per share and valuing the company at around $1.1–1.2 billion. Shares remain about 30% below year-ago levels despite a 60% gain over the past quarter. Getty reported Q2 2025 revenue of $234.9 million and a net loss, with EBITDA margins near 30%. The company holds over $1.3 billion in debt after recent refinancing.
31 October 2025
···
Former Deloitte Chair Joins Conduent Board – Can His Expertise Turn the Tide?

Former Deloitte Chair Joins Conduent Board – Can His Expertise Turn the Tide?

Michael J. Fucci, former Deloitte US Chair, has joined Conduent’s Board of Directors effective October 27. The appointment comes as Conduent’s stock trades near 52-week lows after a 30% drop this year and a recent credit downgrade. Fucci brings four decades of leadership experience, including current board roles at Acadia Healthcare and Flotek Industries. Investors await Conduent’s Nov. 7 earnings for signs of a turnaround.
31 October 2025
·
Roku’s Stunning Comeback – Stock Soars to 52-Week High on Profit Surprise and Amazon Deal

Roku’s Stunning Comeback – Stock Soars to 52-Week High on Profit Surprise and Amazon Deal

Roku shares hit a 52-week high of $107.57 on Oct. 31, 2025, after reporting Q3 revenue of $1.21 billion and its first quarterly profit since 2021. The company raised its full-year outlook, authorized a $50 million buyback, and announced an exclusive ad partnership with Amazon. Roku also expanded its smart TV presence in Europe through a deal with Vestel.
31 October 2025
··
MultiSensor AI’s Wild Stock Ride: Major AI Deal Sparks 42% Surge, $14M Funding Triggers 50% Plunge – What’s Next for MSAI?

MultiSensor AI’s Wild Stock Ride: Major AI Deal Sparks 42% Surge, $14M Funding Triggers 50% Plunge – What’s Next for MSAI?

MultiSensor AI shares soared over 40% after announcing a major U.S. deployment with a global e-commerce logistics firm, then plunged nearly 50% following news of a $14 million private placement at $0.41 per share. The stock rebounded to $2.05 on Oct. 31, 2025, up 55% intraday. Wall Street analysts rate the stock a “Strong Buy” with an average $2.75 target. 2024 revenue was $7.4 million with a $21.5 million net loss.
31 October 2025
··
AbbVie’s Bull Run: Why This $400B Pharma Giant’s Stock Is Just Getting Started

AbbVie’s Bull Run: Why This $400B Pharma Giant’s Stock Is Just Getting Started

AbbVie reported Q3 2025 revenue of $15.78 billion, up 9.1% year-over-year, and raised its full-year EPS outlook after new drugs offset Humira’s decline. Shares traded near $228 in late October, up 28% year-to-date, and the board approved a 5.5% dividend increase for 2026. Skyrizi and Rinvoq sales surged, while the FDA expanded Rinvoq’s indications. AbbVie also announced over $10 billion in acquisitions and new manufacturing investments.
31 October 2025
··
Tiny Biotech INTENSITY THERAPEUTICS Stock Skyrockets on Cancer Therapy Breakthrough – Experts See Big Upside

Biotech Bombshell: Intensity Therapeutics (INTS) Surges Nearly 400% on Major Cancer Trial News

Shares of Intensity Therapeutics closed at $1.32 on Oct. 30, surging nearly 395% intraday after Phase 1/2 trial data for INT230-6 showed a 75% disease-control rate in metastatic cancer. Over a billion shares traded, dwarfing the usual volume. After-hours, the price fell to around $0.90. The company’s market cap remains under $65 million.
31 October 2025
··
1 … 1,223 1,224 1,225 1,226 1,227 … 1,332
Go toTop